跳到主要內容
:::

吳燿宇 醫師

攝護腺癌、泌尿道腫瘤、肉瘤、骨肉瘤、兒童腫瘤

教職 : 助理教授

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 基隆長庚醫院放射腫瘤科主治醫師

學歷

  • 台北醫學大學醫學系

經歷

  • 2022~ 林口長庚醫院放射腫瘤科助理教授級主治醫師
  • 2019-2022 林口長庚醫院放射腫瘤科講師級主治醫師
  • 2017.12-2019.06 林口長庚醫院放射腫瘤科一般主治醫師
  • 2016-2017 林口長庚醫院放射腫瘤科總醫師
  • 2013-2017 林口長庚醫院放射腫瘤科住院醫師
  • 2012-2013 林口長庚醫院一般科住院醫師

學會與認證

  • Taiwan Society for Therapeutic Radiology and Oncology (TASTRO)
  • European Society for Radiotherapy and Oncology (ESTRO)
  • American Society for Radiotherapy and Oncology (ASTRO)

論文及期刊發表

  • Impact of Three-Month Androgen Deprivation Therapy on [68Ga]Ga-PSMA-11 PET/CT Indices in Men with Advanced Prostate Cancer-Results from a Pilot Prospective Study.
  • Proton therapy for prostate cancer: current state and future perspectives.
  • Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy.
  • Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study.
  • Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy.
  • Treatment of Primary Central Nervous System Germinomas With Short-course Induction Chemotherapy Followed by Low-dose Radiotherapy Without a Tumor Bed Boost: Prognostic Impact of Human Chorionic Gonadotropin.
  • Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
  • Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy.
  • Pretreatment lyphocyte count as prognositc factor in patients with head-and-neck cancer.
  • Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
長庚醫院智能服務 有任何問題隨時找我!